Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aolanti for functional dyspepsia
ISRCTN32262691Phase 2Completed
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in functional dyspepsia (FD) comparing Aolanti with Placebo (2 arms). Primary endpoint: Western medicine disease efficacy. Started Mar 2010; status: completed.
02
Drugs
Total Flavonoids of Fructus Aurantii Immaturus
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ISRCTN32262691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN32262691.